The continuing importance of oncology case reports

Peter J Gilbar,Barry R Goldspiel
DOI: https://doi.org/10.1177/1078155220988577
2021-01-20
Journal of Oncology Pharmacy Practice
Abstract:The importance of clinical case reports and case series in medical literature has been acknowledged for centuries. Examples exist from as far back as 1600 BC from the ancient Egyptians, Hippocratic physicians in Greece in 400 BC and Galen in second century Rome.<sup><a class="ref showRefEvent2" href="#">1</a></sup> In 1920, William Osler, recognised as the father of modern medicine, is quoted as stating that physicians should "always note and record the unusual … Publish it. Place it on permanent record as a short, concise note. Such communications are always of value".<sup><a class="ref showRefEvent2" href="#">2</a></sup> For 30 years until 1971, case reports and case series comprised 38% of published articles in three of the top medical journals (<i>Journal of the American Medical Association</i>, the <i>Lancet</i>, and the <i>New England Journal of Medicine</i>).<sup><a class="ref showRefEvent2" href="#">3</a></sup> With the advent of Evidence Based Medicine, the case report was relegated to the lower end of the evidence hierarchy and consequently randomised controlled trials, meta-analysis and systematic reviews received a higher ranking for publication from editors.<sup><a class="ref showRefEvent2" href="#">4</a>–<a class="ref showRefEvent2" href="#">6</a></sup>
oncology,pharmacology & pharmacy
What problem does this paper attempt to address?